Home RxNorm 2700718 trastuzumab-strf 150 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2700718
RxNorm name trastuzumab-strf 150 MG Injection
Display name trastuzumab-strf 150 MG Injection
Full name trastuzumab-strf 150 MG Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:38:51 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761346 Hercessi trastuzumab-strf 351(k) Biosimilar Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 285d2142-5bfa-401c-9246-7de21c4451af trastuzumab-strf 150 MG Injection [PSN] · trastuzumab-strf 150 MG Injection [SCD] 2 4 These highlights do not include all the information needed to use HERCESSI safely and effectively. See full prescribing information for HERCESSI. HERCESSI TM (trastuzumab-strf) for injection, for intravenous use Initial U.S. Approval: 2024 HERCESSI (trastuzumab-strf) is biosimilar* to HERCEPTIN (trastuzumab). 20250321